Skip to main content
The Eurasian Journal of Medicine logoLink to The Eurasian Journal of Medicine
. 2009 Aug;41(2):95–98.

Hemolytic Activities of the Candida Species in Liquid Medium

Hilal Kuzucu Malcok 1, Esin Aktas 1,, Ahmet Ayyildiz 1, Nimet Yigit 2, Halil Yazgi 1
PMCID: PMC4299835  PMID: 25610076

Abstract

Objective

The aim of this study was to evaluate the in vitro hemolytic activities of 107 Candida strains isolated from different clinical samples in liquid medium, and to examine the impact of glucose on this activity.

Materials and Methods

A total of 107 Candida isolates representing seven species (C. albicans, n=28; C. glabrata, n=23; C. tropicalis, n=17; C. parapsilosis, n=16; C. kefyr, n=14; C. krusei, n=5; C. guilliermondii, n=4) were included in the study. The hemolytic activities of the strains were tested on two different Sabouraud dextrose liquid media (SDB) containing 7% defibrinated human blood, one of which is supplemented with 3% glucose and the other without glucose. Cultures were evaluated at the end of a 48-hour incubation. The hemolysis in the media was detected spectrophotometrically by measuring the amount of released hemoglobin and compared with a standard hemolysate which was prepared prior to testing. The degree of hemolysis (percentage value) by an individual strain was calculated according to the following formula below: (Absorbance of supernatant media at 540 nm / Absorbance of standard hemolysate at 540 nm X 100).

Results

In the liquid medium without glucose, strains generally produced hemolysis at low levels. The degree of hemolysis produced by all species increased noticeably in the liquid medium with glucose. Strains of C. albicans and C.kefyr had demonstrated significant hemolytic activity, whereas others had lower activity. C. parapsilosis exerted very little hemolytic activity in the medium with glucose and showed no activity in the medium without glucose.

Conclusion

The hemolytic activities of most Candida species was found to be higher in the human blood-enriched SDB medium containing 3% additive glucose than in the one free from additives. This result indicates that increased blood glucose concentration may contribute to increased hemolytic activity in Candida species, and it suggests a parallel with possible pathogenesis of Candida in patients with diabetes mellitus.

Keywords: Candida species, Hemolytic activity, Human blood saboraud dextrose broth

Introduction

Candida is arguably the archetypal opportunistic human pathogen, having been identified as early as the era of Hippocrates. Today, we know that Candida is a commensal fungus that harmlessly inhabits various niches of the healthy human body [1].

The AIDS epidemic, improved life-sustaining therapies and aggressive anticancer therapies have contributed to the rise in the number of severely immunocompromised patients. This has led to an increase in oral and systemic fungal infections. Several factors, such as adherence, persistence, dimorphism and/or germ tube formation, phenotypic switching, interference with the host defense system, synergism with bacteria and the production of hydrolases (such as lipases and proteases like secreted aspartyl proteinase, phospholipase, esterases, and phosphatases) have been proposed as virulence factors for Candida spp [26].

Hemolysin is another putative virulence factor thought to contribute to candidal pathogenesis. In particular, the secretion of hemolysin - followed by iron acquisition - facilitates hyphal invasion in disseminated candidiasis [79]. While there have been a number of detailed studies on some of hydrolytic enzymes, such as proteases, lipases and phospholipases, papers on the hemolytic activity of Candida spp are few. A complement-mediated hemolysis induced by C. albicans was first reported by Manns et al. [8] and Luo et al. [7], who studied 80 Candida isolates representing 14 species and reported that C. albicans and others showed alpha and beta hemolysis. This was the first study to demonstrate the variable expression profiles of hemolysins in different Candida species with a blood plate assay using a sheep blood SDA medium.

In the present study, we aimed to investigate the hemolytic activity of Candida species isolated from different clinical specimens in two different liquid media.

Materials and Methods

Yeast Strains:

A total of 107 Candida isolates were tested for hemolytic activity. They were recovered from different clinical specimens and consisted of 28 C. albicans, 23 C. glabrata, 17 C. tropicalis, 16 C. parapsilosis, 14 C. kefyr, 5 C. krusei and 4 C. guilliermondii. Of the test organisms, 40 were isolated from the bloodstream, 35 from the oral cavities and pharyngeal swabs, 22 from urine, 6 from vaginal swabs and 4 from sputum. The distribution of the strains by their species and origin are shown in Table 1. Four reference strains (C. albicans ATCC 26555, C. albicans ATCC 90028, C. glabrata ATCC 90030, C. parapsilosis ATCC 90018) were also included in the study. In addition to the yeast strains, one of each strain of Streptococcus pyogenes and Streptococcus sanguis (which induce beta and alpha hemolysis, respectively) were used as positive controls.

Table 1.

The isolation origin of Candida species

Candida species Blood Urine Vaginal swabs Sputum Pharyngeal swabs Oral cavities
C. albicans (n=28) 10 3 5 2 2 6
C. glabrata (n=23) 8 4 - 1 3 7
C. tropicalis (n=17) 9 5 - - 1 2
C. parapsilosis (n=16) 4 4 1 1 2 4
C. kefyr (n=14) 6 5 - - - 3
C. krusei (n=5) 3 1 1
C. guilliermondii (n=4)] - - - - 1 3
Total (n=107) 40 22 6 4 9 26

Primary isolation of the yeasts from pathological samples (except the blood samples) was done on Sabouraud dextrose agar (SDA) supplemented with 1% chloramphenicol, and CHROMagar Candida. The blood samples were inoculated into aerobic media and processed using the BACTEC blood culture system (Becton Dickinson, Sparks, MD). All blood cultures were subcultured on SDA and CHROMagar Candida. The yeast isolates were subsequently identified by a germ tube test, the development of blastospores, chlamydospores and pseudohyphae, and assimilation tests by employing the commercial kit API 20C AUX system (Bio-Merieux, France).

Assessment of Hemolytic Activity:

The hemolytic activities of the strains were measured on two different Sabouraud dextrose liquid media (SDB) (Difco, USA) containing 7% defibrinated human blood, one of which was supplemented with 3% glucose (SDBwG) and the other without glucose (SDBwoG).

Suspensions equal to McFarland 2 turbidity from the pure culture of the yeasts colonies on Sabouraud dextrose agar were prepared. Ten microliters of this suspension were inoculated into 2 ml of SDBwG and SDBwoG media separately. The tubes were incubated at 37°C in 5% CO2 for 48 h. At the and of the incubation, tubes were centrifuged at 1800 g and at 4°C for 10 minutes in order to separate non-hemolyzed erythrocytes. The released hemoglobin in the supernatants was then quantified by spectroscopic analysis using the Cyanmethemoglobin method as follows: Ten microliters of supernatants were transferred to sterile polyethylene tubes, and five milliliters of Drabkin’s reagent (KCN, K3Fe (CN)6, NaHCO3, KH2PO4, TritonX-100) were added. The absorbance of the mixture was measured at 540 nm. On the other hand, standard hemolysat suspension was prepared in order to compare the hemoglobin content of this standard with those of the test samples. One hundred microliters of defibrinated human blood was mixed with 1430 microliters cold water (final dilution of blood is 7%), and incubated at 4°C for 30 minutes in order to lyse the erythrocytes. The hemoglobin content of this standard was then determined using the same procedure as above. The degree of the hemoleysis (persentage value) by an individual strains was calculated according to the formula below: (Absorbance of test tubes / absorbance of standard hemolysat) × 100 [1012].

Statistical Analysis:

Statistical analyses were performed using Student’s t-test (independent samples test) in SPSS, version 11.0.

Results

The mean average of hemolysis percentage by Candida isolates in two different liquid media is presented in Table 2, and the tube images for the expression profiles of hemolysins by S. sanguis, C. albicans, C .parapsilosis, and C. glabrata are shown in Figure 1.

Table 2.

Mean average hemolysis percentage by Candida isolates in two different liquid media.

Candida species Human blood SDB without glucose (%) Human blood SDB with 3% glucose (%)
C.albicans (n:28) 32.9 49.6
C.glabrata (n:23) 27.6 43.0
C.tropicalis (n:17) 27.8 40.0
C.parapsilosis (n:16) 0.0 6.8
C.kefyr (n:14) 40.1 47.4
C.krusei (5) 17.2 28.3
C.guillermondii (4) 18.1 21.5
C.albicans ATCC 90028* 47.2 61.1
C.albicans ATCC 26555* 42.6 58.1
C.glabrata ATCC 90030* 44.4 47.2
C.parapsilosis ATCC 90018* 0.0 0.0
S.pyogenes* 63.8 83.3
S. sanguis* 44.4 58.3
*

single value, not average

Fig. 1.

Fig. 1

Eolysis profiles of various Candida species in human blood SDB (3% glucose). From left to right: SDB without blood, S. sanguis, C. albicans, C.parapsilosis and C.glabrata.

As seen in Table 2, the hemolytic activities of C. albicans, C. glabrata, C. tropicalis and C. kefyr were higher than in other species. The mean average hemolysis percentage for these species (in SDBwG medium) varied between 40% and 49.6%. C. krusei, C. guilliermondii and C. parapsilosis showed weak hemolytic activity in the same medium; the mean average hemolysis percentage for these species ranged between 6.8% and 28.3%. The hemolytic activities of all the Candida strains in SDBwoG medium were lower than that of SDBwG medium. None of the 16 C. parapsilosis isolates exhibited hemolytic activity in SDBwoG medium. The differences between the results obtained from the two media were statistically significant (C. albicans; t=2.93, P<0.01, C. glabrata; t=3.23, P<0.01, C. tropicalis; t=2.25, P<0.05, C. parapsilosis; t=2.82, P<0.001). C. krusei and C. guilliermondii were not calculated because sample numbers were low.

Discussion

The ability of pathogenic organisms to acquire elemental iron has been shown to be of critical importance in their survival and helps to establish infection within the mammalian host. Because there is little free iron in the human host, most pathogens acquire iron indirectly from commonly available iron-containing compounds such as hemoglobin. In order to do so, however, the pathogen must be equipped with a mechanism that destroys the heme moiety and enables it to extract the elemental iron. The enzymes involved in this activity are classified as hemolysins [7,8,9,13,14].

Studies on the activity of hemolysin in Candida spp are limited [7,8]. A complement-mediated hemolysis induced by C. albicans was first reported by Manns et al. [8], but the literature revealed no other reports on the hemolytic activity of the non-albicans species of Candida. Luo et al. [7] demonstrate that, both qualitatively and quantitatively, the hemolytic activity in a wide spectrum of Candida species belong to 14 genera. The same authors suggested that the hemolysis so induced could be categorized according to conventional microbiologic nomenculature as complete (beta), incomplete (alpha) or no hemolysis (gamma or non). Thus the terms alpha and beta hemolysis used to describe the different patterns of hemolysis in Candida spp can only be regarded as descriptive because the exact nature of these variants and their underlying mechanisms are yet to be fully explored [7]. However some authors indicate that there are some genetic attributes that contribute to the hemolytic activity of Candida species, and also there is a significant positive correlation between the phenotypic and genotypic expressions of hemolytic activity [15,16].

The modified plate assay with sheep blood SDA medium described in the previous report is simple, reproducible, and sensitive, and is a relatively fast screening method for assessing the hemolytic activity of Candida spp [7,8]. Recently, we reported that Candida species, including C. albicans, C. tropicalis, C. glabrata, C. kefyr and C. krusei, exhibit varying ability to produce hemolysin on SDA media containing human, rabbit and sheep blood (supplemented with 3% glucose) [17]. Nevertheless, the literature provides no information about the relative performance of the liquid medium enriched with human blood on the hemolytic activity of Candida isolates.

In this study, C. albicans, C. glabrata, C. tropicalis and C. kefyr exhibited higher hemolytic activities in human blood SDBwG at 48 h, with the mean average for hemolysis percentages as 49.6%, 43.0%, 40.0% and 47.4%; other mean averages include those of C. krusei (28.3%) C. guilliermondii (21.5%) and C. parapsilosis (6.8%) (Table 2). The hemolytic activity of the same strains in human blood SDBwoG was lower than that of the SDBwG medium. C. parapsilosis isolates did not exhibit any hemolytic activity in SDBwoG medium. The differences between hemolytic activities of the strains in two different media were statistically significant (C. albicans; t=2.93, p<0.01, C. glabrata; t=3.23, p<0.01, C. tropicalis; t=2.25, p<0.05, C. parapsilosis; t=2.82, p<0.001).

Luo et al. [7] reported that C. parapsilosis strains did not exhibit alpha and beta hemolysis on sheep blood Sabouraud dextrose agar. In our previous study, we demonstrated that C. parapsilosis strains did not exhibit any hemolytic activities on SDA media enriched with human, sheep and rabbit blood [17]. In the present study, C. parapsilosis strains showed low hemolytic activity in human blood SDB with 3% glucose medium, but no activity in the medium without glucose.

Manns et al. [8] defined the conditions under which C. albicans can display hemolytic activity, but discovered that hemolysis was non-existent when no glucose was available in the culture medium. On the other hand, Luo et al. [7] have tested 80 Candida isolates from clinical sources in different geographical locales and detected only alpha, and not any beta, hemolysis in experiments with glucose-free sheep blood agar. Tsang et al. [9] reported that oral C. albicans isolates from type 2 diabetes mellitus patients posses significantly higher hemolysin activity than isolates from healthy, non-DM controls. The same authors suggested that an increased blood glucose concentration may contribute, directly or indirectly, to increased hemolysin activity among C. albicans isolates in DM patients and, in addition, an increased salivary glucose concentration in DM patients may also influence hemolysin production in C. albicans [9]. In our study, the degree of hemolysis produced by all species increased in the liquid medium with glucose. The results of the present study are consistent with these findings.

Another result of this study is that the hemolytic activity of Candida species did not differ by isolation origin. This result is supported by the results of other research [7,17].

In conclusion, we report here that Candida spp displayed different hemolytic activity in human blood SDBwG and human blood SDBwoG media. This activity was found to be higher in the SDBwG medium than in the SDBwoG medium. This result suggests that an increased blood glucose concentration may contribute to increased hemolysin activity. However, further studies are needed to understand the nature of the hemolytic factors and their host–pathogen relationships associated with candidal infections.

Footnotes

Conflict interest statement The authors declare that they have no conflict of interest to the publication of this article.

References

  • 1.Seneviratne CJ, Jın L, Samaranayake LP. Biofilm lifestyle of Candida: a mini review. Oral Diseases. 2008;14:582–90. doi: 10.1111/j.1601-0825.2007.01424.x. [DOI] [PubMed] [Google Scholar]
  • 2.Brostt A, Fluit AC. High levels of hydrolytic enzymes secreted by Candida albicans isolates involved in respiratory infections. J Med Microbiology. 2003;52:971–4. doi: 10.1099/jmm.0.05228-0. [DOI] [PubMed] [Google Scholar]
  • 3.Ibrahim AS, Mirbod F, Filler SG, et al. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun. 1995;63:1993–8. doi: 10.1128/iai.63.5.1993-1998.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Rodrigues AG, Pina-Vaz C, Costa-de-Oliveira, Tavares C. Expression of plasma coagulase among pathogenic Candida species. J Clin Microbiol. 2003;41:5792–3. doi: 10.1128/JCM.41.12.5792-5793.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Schaller M, Borelli C, Korting HC, Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses. 2005;48:365–77. doi: 10.1111/j.1439-0507.2005.01165.x. [DOI] [PubMed] [Google Scholar]
  • 6.Yang LY. Virulence factors of Candida species J. Microbiol Immunol Infect. 2003;36:223–8. [PubMed] [Google Scholar]
  • 7.Luo G, Samaranayake LP, Yau JYY. Candida species exhibit differential in vitro hemolytic activities. J Clin Microbiol. 2001;39:2971–4. doi: 10.1128/JCM.39.8.2971-2974.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Manns MJ, Mosser MD, Buckley RH. Production of a hemolytic factor by Candida albicans. Infect Immun. 1994;62:5154–6. doi: 10.1128/iai.62.11.5154-5156.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Tsang CSP, Chu FCS, Leung WK, Jin LJ, Samaranyake LP, Siu SC. Phospholipase, proteinase and hemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus. J Med Microbiol. 2007;56:1393–8. doi: 10.1099/jmm.0.47303-0. [DOI] [PubMed] [Google Scholar]
  • 10.Ichıkawa T, Kıtazakı T, Matsushıta Y, et al. Optically Active Antifungal Azoles. XII.1) Synthesis and antifungal activity of the water-soluble prodrugs of 1-[(1R,2R)-2-(2,4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1 yl) propyl]-3-[4-(1H-1-tetrazolyl) phenyl]-2 imidazolidinone. Chem Pharm Bull. 2001;49:1102–9. doi: 10.1248/cpb.49.1102. [DOI] [PubMed] [Google Scholar]
  • 11.McCool L, Mai H, Essmann M, Larsen B. Tetracycline effects on Candida albicans virulence factors. Infect Dis Obstet Gynecol. 2008:493508. doi: 10.1155/2008/493508. Published online 29 May 2008, doi: 10.1155/2008/493508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Nikawa H, Fukushima H, Makihira S, Hamada T, Samaranyake LP. Fungicidal effect of three new synthetic cationic peptides againts Candida albicans. Oral Dis. 2004;10:221–8. doi: 10.1111/j.1601-0825.2004.01010.x. [DOI] [PubMed] [Google Scholar]
  • 13.Lineras BEC, Loreto SE, Silveira PC, Pozatti P, Scheid AL, Santurio MJ, Alves HS. Enzymatic and hemolytic activities of Candida dubliniensis strains. Rev Inst Med Trop S Paulo. 2007;49:203–6. doi: 10.1590/s0036-46652007000400001. [DOI] [PubMed] [Google Scholar]
  • 14.Shinobu CS, Ogatta SFY, Bizerra F, Furlenato L, Peralta RM, Svidzinski TIE, Consolaro MEL. Lack of association between genotypes and virulence factors in C. albicans strains isolated from vaginal secretion. Brazillian J Microbiol. 2007;38:467–1. [Google Scholar]
  • 15.Lachke SA, Srıkantha T, Tsaı LK, Danıels K, Soll DR. Phenotypic switching in Candida glabrata involves phase-specific regulation of the metallothionein gene MT-II and the newly discovered hemolysin gene HLP. Infect and Immun. 2000;68:884–95. doi: 10.1128/iai.68.2.884-895.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Luo G, Samaranayake LP, Cheung BPK, Tang G. Reverse transcriptase polymerase chain reaction (RT-PCR) detection of HPL gene expression in Candida glabrata and its possible role in in vitro haemolysin production. APMIS. 2004;112:283–90. doi: 10.1111/j.1600-0463.2004.apm11204-0509.x. [DOI] [PubMed] [Google Scholar]
  • 17.Yigit N, Aktas E. Comparison of the efficacy of different blood medium in determining the hemolytic activity of Candida species. Journal de Mycologie Medicale. 2009;19:110–5. [Google Scholar]

Articles from The Eurasian Journal of Medicine are provided here courtesy of Ataturk University School of Medicine

RESOURCES